Different Radiological Findings between Hepatocellular Carcinoma (HCC) after HCV Eradication with Direct Acting Antivirals (DAAs) and HCV-RNA Positive HCC

被引：0

作者：

Shimizu, Takao ^{[1
]}

Tsuchiya, Kaoru ^{[1
]}

Takada, Hitomi ^{[1
]}

Tamaki, Nobuharu ^{[1
]}

Yasui, Yutaka ^{[1
]}

Nakanishi, Hiroyuki ^{[1
]}

Itakura, Jun ^{[1
]}

Takahashi, Yuka ^{[1
]}

Kurosaki, Masayuki ^{[1
]}

Izumi, Namiki ^{[1
]}

机构：

[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo, Japan

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

865

引用

页码：508A / 509A

页数：2

共 50 条

[1] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
Cabibbo, G.
Cacciola, I.
Cannavo, M. R.
Madonia, S.
Calvaruso, V.
Petta, S.
Distefano, M.
Larocca, L.
Prestileo, T.
Tine, F.
Digiacomo, A.
Bertino, G.
Giannitrapani, L.
Benanti, F.
Davi, A.
Volpes, R.
Scalisi, I.
Iacobello, C.
Mazzola, G.
Cartabellotta, F.
Guarneri, L.
Portelli, V.
Averna, A.
Russello, M.
Scifo, G.
Squadrito, G.
Raimondo, G.
Craxi, A.
Di Marco, V.
Camma, C.
[J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
[2] Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
Calvaruso, V.
Cabibbo, G.
Cacciola, I.
Petta, S.
Madonia, S.
Bellia, A.
Tine, F.
Distefano, M.
Giannitrapani, L.
Prestileo, T.
Mazzola, G.
Davi, A.
Larocca, L.
Ardiri, A.
Digiacomo, A.
Gussio, M.
Guarneri, L.
Magro, A.
Averna, A.
Iacobello, C.
Scalisi, I.
Cartabellotta, F.
Savalli, F.
Russello, M.
Scifo, G.
Squadrito, G.
Camma, C.
Raimondo, G.
Craxi, A.
Di Marco, V.
[J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E60 - E60
[3] HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
Emamaullee, Juliet A.
Bral, Mariusz
Meeberg, Glenda
Montano-Loza, Aldo J.
Bain, Vincent G.
Burak, Kelly Warren
Bigam, David
Shapiro, A. M. James
Kneteman, Norman
[J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
[4] PERSISTENCE OF HCV-RNA IS ASSOCIATED WITH RISK OF HEPATOCELLULAR-CARCINOMA (HCC) DEVELOPMENT
BRUNO, S
VILLA, E
CHIESA, A
ROSSI, S
BORZIO, F
GROTTOLA, A
BUTTAFOCO, P
ZUIN, M
PODDA, M
[J]. GASTROENTEROLOGY, 1993, 104 (04) : A881 - A881
[5] Editorial - HCC in HCV patients and the direct acting antivirals: is there really a link?
Marrone, A.
Franci, G.
Perrella, A.
Nevola, R.
Chianese, A.
Adinolfi, L. E.
Sasso, F. C.
Rinaldi, L.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 983 - 987
[6] Eradication of HCV induced by direct-acting antivirals is associated with a 79% reduction in HCC risk.
Ioannou, George N.
Green, Pamela
Berry, Kristin
[J]. HEPATOLOGY, 2017, 66 : 82A - 83A
[7] Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients
Bari, Shahla
Chan, Austin
Olanipekun, Titilope
Chawla, Saurabh
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S493 - S494
[8] RISK OF HCC IN HCV RELATED CIRRHOSIS AFTER HCV CLEARANCE WITH DIRECT ACTING ANTIVIRALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Rassameehiran, Supannee
Patil, Rashmee
Patel, Ruchi
Sood, Gagan K.
[J]. GASTROENTEROLOGY, 2017, 152 (05) : S1163 - S1163
[9] Effect of HCV-RNA eradication on HCC occurrence and survival rate in hepatitis C patients
Sasaki, Masato
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 174 - 174
[10] Unusually High HCC Rates Among Patients With HCV Cirrhosis After Treatment With Direct Acting Antivirals
Ravi, Sujan
Kodali, Sudha
Simpson, Heather
Alkurdi, Basem
McGuire, Brendan M.
Singal, Ashwani
[J]. HEPATOLOGY, 2016, 64 : 663A - 663A

← 1 2 3 4 5 →